PH vs SGMT · P/E 28, rev $19.85B vs rev $2.0M
Parker-Hannifin Corporation (PH) versus Sagimet Biosciences Inc. Series A Common Stock (SGMT) — a side-by-side from cached financials, not a winner call.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Latest reported SGMT revenue for 2023-09-30 was $2.0M. Net income was -$6.4M. Revenue was up 0.0% from 2023-07-31 to 2023-09-30. SGMT currently screens at market cap $403.2M.
PH currently screens at market cap $91.89B and trailing P/E 27.7. SGMT currently screens at market cap $403.2M.
Not investment advice. Open the PH and SGMT stock pages for the full models.
Not investment advice.